ID   PTAFR_HUMAN             Reviewed;         342 AA.
AC   P25105; A3KMC8; A8K2H5;
DT   01-MAY-1992, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1992, sequence version 1.
DT   07-APR-2021, entry version 195.
DE   RecName: Full=Platelet-activating factor receptor;
DE            Short=PAF-R;
DE            Short=PAFr;
GN   Name=PTAFR; Synonyms=PAFR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Granulocyte;
RX   PubMed=1656963; DOI=10.1016/s0006-291x(05)81261-6;
RA   Ye R.D., Prossnitz E.R., Zou A., Cochrane C.G.;
RT   "Characterization of a human cDNA that encodes a functional receptor for
RT   platelet activating factor.";
RL   Biochem. Biophys. Res. Commun. 180:105-111(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND INDUCTION.
RC   TISSUE=Leukocyte;
RX   PubMed=1657923;
RA   Nakamura M., Honda Z., Izumi T., Sakanaka C., Mutoh H., Minami M., Bito H.,
RA   Seyama Y., Matsumoto T., Noma M., Shimizu T.;
RT   "Molecular cloning and expression of platelet-activating factor receptor
RT   from human leukocytes.";
RL   J. Biol. Chem. 266:20400-20405(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SUBCELLULAR LOCATION.
RC   TISSUE=Leukocyte;
RX   PubMed=1374385;
RA   Kunz D., Gerard N.P., Gerard C.;
RT   "The human leukocyte platelet-activating factor receptor. cDNA cloning,
RT   cell surface expression, and construction of a novel epitope-bearing
RT   analog.";
RL   J. Biol. Chem. 267:9101-9106(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Fetal liver;
RX   PubMed=1322356; DOI=10.1016/0888-7543(92)90162-l;
RA   Seyfried C.E., Schweickart V.L., Godiska R., Gray P.W.;
RT   "The human platelet-activating factor receptor gene (PTAFR) contains no
RT   introns and maps to chromosome 1.";
RL   Genomics 13:832-834(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Heart ventricle;
RX   PubMed=1281995; DOI=10.1016/0006-291x(92)92245-s;
RA   Sugimoto T., Tsuchimochi H., McGregor C.G.A., Mutoh H., Shimizu T.,
RA   Kurachi Y.;
RT   "Molecular cloning and characterization of the platelet-activating factor
RT   receptor gene expressed in the human heart.";
RL   Biochem. Biophys. Res. Commun. 189:617-624(1992).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Cervix carcinoma;
RA   Behal R.H., Debuysere M.S., Olson M.S.;
RT   "Nucleotide sequence of platelet-activating-factor receptor derived from
RT   HeLa cell genomic DNA and Rhesus monkey genomic DNA.";
RL   Submitted (DEC-1992) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8383507; DOI=10.1165/ajrcmb/8.3.240;
RA   Chase P.B., Halonen M., Regan J.W.;
RT   "Cloning of a human platelet-activating factor receptor gene: evidence for
RT   an intron in the 5'-untranslated region.";
RL   Am. J. Respir. Cell Mol. Biol. 8:240-244(1993).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RA   Warren C.N., Aronstam R.S., Sharma S.V.;
RT   "cDNA clones of human proteins involved in signal transduction sequenced by
RT   the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Umbilical cord blood;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [13]
RP   INTERACTION WITH ARRB1.
RX   PubMed=16709866; DOI=10.4049/jimmunol.176.11.7039;
RA   McLaughlin N.J., Banerjee A., Kelher M.R., Gamboni-Robertson F., Hamiel C.,
RA   Sheppard F.R., Moore E.E., Silliman C.C.;
RT   "Platelet-activating factor-induced clathrin-mediated endocytosis requires
RT   beta-arrestin-1 recruitment and activation of the p38 MAPK signalosome at
RT   the plasma membrane for actin bundle formation.";
RL   J. Immunol. 176:7039-7050(2006).
RN   [14]
RP   VARIANTS ASP-224 AND SER-338.
RX   PubMed=10391209; DOI=10.1038/10290;
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RT   "Characterization of single-nucleotide polymorphisms in coding regions of
RT   human genes.";
RL   Nat. Genet. 22:231-238(1999).
RN   [15]
RP   ERRATUM OF PUBMED:10391209.
RA   Cargill M., Altshuler D., Ireland J., Sklar P., Ardlie K., Patil N.,
RA   Shaw N., Lane C.R., Lim E.P., Kalyanaraman N., Nemesh J., Ziaugra L.,
RA   Friedland L., Rolfe A., Warrington J., Lipshutz R., Daley G.Q.,
RA   Lander E.S.;
RL   Nat. Genet. 23:373-373(1999).
CC   -!- FUNCTION: Receptor for platelet activating factor, a chemotactic
CC       phospholipid mediator that possesses potent inflammatory, smooth-muscle
CC       contractile and hypotensive activity. Seems to mediate its action via a
CC       G protein that activates a phosphatidylinositol-calcium second
CC       messenger system. {ECO:0000269|PubMed:1281995,
CC       ECO:0000269|PubMed:1374385, ECO:0000269|PubMed:1656963,
CC       ECO:0000269|PubMed:1657923}.
CC   -!- SUBUNIT: Interacts with ARRB1. {ECO:0000269|PubMed:16709866}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:1374385};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:1374385}.
CC   -!- TISSUE SPECIFICITY: Expressed in the placenta, lung, left and right
CC       heart ventricles, heart atrium, leukocytes and differentiated HL-60
CC       granulocytes. {ECO:0000269|PubMed:1281995, ECO:0000269|PubMed:1656963,
CC       ECO:0000269|PubMed:1657923}.
CC   -!- INDUCTION: By CSF2/GM-CSF, IL5/interleukin-5 and n-butyrate.
CC       {ECO:0000269|PubMed:1657923}.
CC   -!- SIMILARITY: Belongs to the G-protein coupled receptor 1 family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00521}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M80436; AAA60001.1; -; mRNA.
DR   EMBL; D10202; BAA01050.1; -; mRNA.
DR   EMBL; M76674; AAA60002.1; -; mRNA.
DR   EMBL; M88177; AAA60214.1; -; Genomic_DNA.
DR   EMBL; S52624; AAB24695.2; -; mRNA.
DR   EMBL; L07334; AAA60108.1; -; mRNA.
DR   EMBL; S56396; AAB25755.1; -; Genomic_DNA.
DR   EMBL; AY275466; AAP32298.1; -; mRNA.
DR   EMBL; BT009801; AAP88803.1; -; mRNA.
DR   EMBL; AK290240; BAF82929.1; -; mRNA.
DR   EMBL; CH471059; EAX07711.1; -; Genomic_DNA.
DR   EMBL; BC013816; AAH13816.1; -; mRNA.
DR   EMBL; BC063000; AAH63000.1; -; mRNA.
DR   CCDS; CCDS318.1; -.
DR   PIR; A40191; A40191.
DR   RefSeq; NP_000943.1; NM_000952.4.
DR   RefSeq; NP_001158193.1; NM_001164721.1.
DR   RefSeq; NP_001158194.1; NM_001164722.2.
DR   RefSeq; NP_001158195.1; NM_001164723.2.
DR   PDB; 2B0X; Model; -; A=1-342.
DR   PDBsum; 2B0X; -.
DR   SMR; P25105; -.
DR   BioGRID; 111696; 22.
DR   CORUM; P25105; -.
DR   IntAct; P25105; 15.
DR   MINT; P25105; -.
DR   STRING; 9606.ENSP00000362965; -.
DR   BindingDB; P25105; -.
DR   ChEMBL; CHEMBL250; -.
DR   DrugBank; DB09166; Etizolam.
DR   DrugBank; DB02261; Platelet Activating Factor.
DR   DrugBank; DB11614; Rupatadine.
DR   DrugCentral; P25105; -.
DR   GuidetoPHARMACOLOGY; 334; -.
DR   SwissLipids; SLP:000001565; -.
DR   TCDB; 9.A.14.13.3; the g-protein-coupled receptor (gpcr) family.
DR   GlyGen; P25105; 1 site.
DR   iPTMnet; P25105; -.
DR   PhosphoSitePlus; P25105; -.
DR   BioMuta; PTAFR; -.
DR   DMDM; 129557; -.
DR   EPD; P25105; -.
DR   jPOST; P25105; -.
DR   MassIVE; P25105; -.
DR   PaxDb; P25105; -.
DR   PeptideAtlas; P25105; -.
DR   PRIDE; P25105; -.
DR   ProteomicsDB; 54261; -.
DR   ABCD; P25105; 1 sequenced antibody.
DR   Antibodypedia; 30903; 184 antibodies.
DR   DNASU; 5724; -.
DR   Ensembl; ENST00000305392; ENSP00000301974; ENSG00000169403.
DR   Ensembl; ENST00000373857; ENSP00000362965; ENSG00000169403.
DR   Ensembl; ENST00000539896; ENSP00000442658; ENSG00000169403.
DR   GeneID; 5724; -.
DR   KEGG; hsa:5724; -.
DR   UCSC; uc001bpl.4; human.
DR   CTD; 5724; -.
DR   DisGeNET; 5724; -.
DR   GeneCards; PTAFR; -.
DR   HGNC; HGNC:9582; PTAFR.
DR   HPA; ENSG00000169403; Tissue enriched (blood).
DR   MIM; 173393; gene.
DR   neXtProt; NX_P25105; -.
DR   OpenTargets; ENSG00000169403; -.
DR   PharmGKB; PA33933; -.
DR   VEuPathDB; HostDB:ENSG00000169403.11; -.
DR   eggNOG; ENOG502QTQI; Eukaryota.
DR   GeneTree; ENSGT00980000198579; -.
DR   HOGENOM; CLU_009579_8_2_1; -.
DR   InParanoid; P25105; -.
DR   OMA; KCSRQTT; -.
DR   OrthoDB; 800525at2759; -.
DR   PhylomeDB; P25105; -.
DR   TreeFam; TF350009; -.
DR   PathwayCommons; P25105; -.
DR   Reactome; R-HSA-373076; Class A/1 (Rhodopsin-like receptors).
DR   Reactome; R-HSA-416476; G alpha (q) signalling events.
DR   Reactome; R-HSA-6783783; Interleukin-10 signaling.
DR   Reactome; R-HSA-6798695; Neutrophil degranulation.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   SIGNOR; P25105; -.
DR   BioGRID-ORCS; 5724; 5 hits in 998 CRISPR screens.
DR   ChiTaRS; PTAFR; human.
DR   GeneWiki; Platelet-activating_factor_receptor; -.
DR   GenomeRNAi; 5724; -.
DR   Pharos; P25105; Tchem.
DR   PRO; PR:P25105; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P25105; protein.
DR   Bgee; ENSG00000169403; Expressed in blood and 229 other tissues.
DR   Genevisible; P25105; HS.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0030667; C:secretory granule membrane; TAS:Reactome.
DR   GO; GO:0070821; C:tertiary granule membrane; TAS:Reactome.
DR   GO; GO:0045028; F:G protein-coupled purinergic nucleotide receptor activity; IBA:GO_Central.
DR   GO; GO:0004930; F:G protein-coupled receptor activity; TAS:ProtInc.
DR   GO; GO:0001530; F:lipopolysaccharide binding; IEA:Ensembl.
DR   GO; GO:0001875; F:lipopolysaccharide immune receptor activity; IEA:Ensembl.
DR   GO; GO:0051019; F:mitogen-activated protein kinase binding; IEA:Ensembl.
DR   GO; GO:0005543; F:phospholipid binding; IDA:UniProtKB.
DR   GO; GO:0004992; F:platelet activating factor receptor activity; IDA:UniProtKB.
DR   GO; GO:1904317; P:cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine; IEA:Ensembl.
DR   GO; GO:0071320; P:cellular response to cAMP; IEA:Ensembl.
DR   GO; GO:0071398; P:cellular response to fatty acid; IEA:Ensembl.
DR   GO; GO:0071258; P:cellular response to gravity; IEA:Ensembl.
DR   GO; GO:0006935; P:chemotaxis; TAS:ProtInc.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0006955; P:immune response; TAS:ProtInc.
DR   GO; GO:0006954; P:inflammatory response; TAS:ProtInc.
DR   GO; GO:0032959; P:inositol trisphosphate biosynthetic process; IEA:Ensembl.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0045776; P:negative regulation of blood pressure; IEA:Ensembl.
DR   GO; GO:0043312; P:neutrophil degranulation; TAS:Reactome.
DR   GO; GO:0007567; P:parturition; IEA:Ensembl.
DR   GO; GO:0048015; P:phosphatidylinositol-mediated signaling; IDA:UniProtKB.
DR   GO; GO:0002693; P:positive regulation of cellular extravasation; IEA:Ensembl.
DR   GO; GO:1904306; P:positive regulation of gastro-intestinal system smooth muscle contraction; IEA:Ensembl.
DR   GO; GO:0060732; P:positive regulation of inositol phosphate biosynthetic process; IEA:Ensembl.
DR   GO; GO:0032755; P:positive regulation of interleukin-6 production; IEA:Ensembl.
DR   GO; GO:1903238; P:positive regulation of leukocyte tethering or rolling; IEA:Ensembl.
DR   GO; GO:1904303; P:positive regulation of maternal process involved in parturition; IEA:Ensembl.
DR   GO; GO:0043315; P:positive regulation of neutrophil degranulation; IEA:Ensembl.
DR   GO; GO:0010863; P:positive regulation of phospholipase C activity; IEA:Ensembl.
DR   GO; GO:1904058; P:positive regulation of sensory perception of pain; IEA:Ensembl.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IEA:Ensembl.
DR   GO; GO:1904300; P:positive regulation of transcytosis; IEA:Ensembl.
DR   GO; GO:0045727; P:positive regulation of translation; IEA:Ensembl.
DR   GO; GO:0032760; P:positive regulation of tumor necrosis factor production; IEA:Ensembl.
DR   GO; GO:0045907; P:positive regulation of vasoconstriction; IEA:Ensembl.
DR   GO; GO:1902943; P:positive regulation of voltage-gated chloride channel activity; IEA:Ensembl.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0071548; P:response to dexamethasone; IEA:Ensembl.
DR   GO; GO:0009609; P:response to symbiotic bacterium; IEA:Ensembl.
DR   GO; GO:0045056; P:transcytosis; IEA:Ensembl.
DR   InterPro; IPR000276; GPCR_Rhodpsn.
DR   InterPro; IPR017452; GPCR_Rhodpsn_7TM.
DR   InterPro; IPR002282; PAF_rcpt.
DR   Pfam; PF00001; 7tm_1; 1.
DR   PRINTS; PR00237; GPCRRHODOPSN.
DR   PRINTS; PR01153; PAFRECEPTOR.
DR   PROSITE; PS00237; G_PROTEIN_RECEP_F1_1; 1.
DR   PROSITE; PS50262; G_PROTEIN_RECEP_F1_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Chemotaxis; Disulfide bond;
KW   G-protein coupled receptor; Glycoprotein; Membrane; Receptor;
KW   Reference proteome; Transducer; Transmembrane; Transmembrane helix.
FT   CHAIN           1..342
FT                   /note="Platelet-activating factor receptor"
FT                   /id="PRO_0000070092"
FT   TOPO_DOM        1..16
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        17..38
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        39..54
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        55..74
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        75..91
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        92..113
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        114..133
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        134..155
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        156..184
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        185..205
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        206..233
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        234..254
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        255..276
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        277..296
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        297..342
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        169
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        90..173
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00521"
FT   VARIANT         224
FT                   /note="A -> D (in dbSNP:rs5938)"
FT                   /evidence="ECO:0000269|PubMed:10391209"
FT                   /id="VAR_011851"
FT   VARIANT         338
FT                   /note="N -> S (in dbSNP:rs5939)"
FT                   /evidence="ECO:0000269|PubMed:10391209"
FT                   /id="VAR_011852"
FT   CONFLICT        28
FT                   /note="L -> P (in Ref. 6; AAA60108)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        66
FT                   /note="F -> L (in Ref. 6; AAA60108)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        95
FT                   /note="C -> R (in Ref. 6; AAA60108)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        227..228
FT                   /note="KR -> TG (in Ref. 4; AAA60214)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        227..228
FT                   /note="KR -> TT (in Ref. 6; AAA60108)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        247
FT                   /note="P -> A (in Ref. 6; AAA60108)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        316
FT                   /note="K -> N (in Ref. 5; AAB24695)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   342 AA;  39203 MW;  890073C9EBA79228 CRC64;
     MEPHDSSHMD SEFRYTLFPI VYSIIFVLGV IANGYVLWVF ARLYPCKKFN EIKIFMVNLT
     MADMLFLITL PLWIVYYQNQ GNWILPKFLC NVAGCLFFIN TYCSVAFLGV ITYNRFQAVT
     RPIKTAQANT RKRGISLSLV IWVAIVGAAS YFLILDSTNT VPDSAGSGNV TRCFEHYEKG
     SVPVLIIHIF IVFSFFLVFL IILFCNLVII RTLLMQPVQQ QRNAEVKRRA LWMVCTVLAV
     FIICFVPHHV VQLPWTLAEL GFQDSKFHQA INDAHQVTLC LLSTNCVLDP VIYCFLTKKF
     RKHLTEKFYS MRSSRKCSRA TTDTVTEVVV PFNQIPGNSL KN
//
